Search

Search Constraints

You searched for: Author/Creator Haddad, Robert I.

Search Results

1. 57 Local Control Following Combination Hypofractionated Radiotherapy and Pembrolizumab in a Phase II Trial of Recurrent or Metastatic Adenoid Cystic Carcinoma Patients. (October 2019)

2. A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma. (August 2021)

3. Acupuncture for Chemoradiation Therapy-Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham-Controlled Trial. (10th August 2016)

4. Acupuncture for Chemoradiation Therapy‐Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham‐Controlled Trial. (10th August 2016)

6. Association between radiation dose to organs at risk and acute patient reported outcome during radiation treatment for head and neck cancers. Issue 6 (31st March 2022)

8. Biomarkers predictive of response to pembrolizumab in head and neck cancer. (7th December 2022)

9. Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study. (October 2021)

10. Chemotherapy after immune checkpoint blockade in patients with recurrent, metastatic squamous cell carcinoma of the head and neck. (June 2020)